TTrialPathMatch Me to Trials
← Back to trials
RecruitingAortic Arch AneurysmAortic Arch DissectionChronic Aortic Dissection

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

Eligible age

18–80 yrs

Accepts

All genders

Locations

15 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.

Sponsor: Artivion Inc.

Where it's recruiting

Alabama

Birmingham

California

Los Angeles

Colorado

Aurora

District of Columbia

Washington D.C.

Florida

Gainesville

Georgia

Atlanta

Illinois

Chicago

Maryland

Baltimore

Michigan

Ann Arbor

New York

New York · The Bronx

Ohio

Cleveland

Pennsylvania

Philadelphia · Pittsburgh

Source: ClinicalTrials.gov · NCT07089576 · last updated 2026-10-15

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA · TrialPath